Request Deal Involvement
Goldman Sachs Alternatives led a $132m Series B round in Alterome Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
pr advisors
Argot Partners
or
Principals
bidder
GOLDMAN SACHS ASSET MANAGEMENT
bidder
CANAAN PARTNERS
target
ALTEROME THERAPEUTICS
bidder
DRIEHAUS CAPITAL
bidder
THE INVUS GROUP LLC
bidder
DIGITALIS VENTURES
bidder
COLT VENTURES
bidder
BLUE OWL CAPITAL
bidder
ORBIMED PE
bidder
NEXTECH INVEST
bidder
VIDA VENTURES
bidder
BOXER CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite